Research and development investment in new technologies, new products and improvements to existing products
First written in FY2016. 29 of 37 entries say "Restated". Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥863 million.」
R&D expenses increased from ¥802 million in the previous fiscal year to ¥863 million. Development and research continued in areas including BIM drawing review for building approvals, 3DGS, AR, and AI/XR. - FY2026-H1RestatedAnnual report
「Group-wide R&D expenses for the current interim consolidated period were ¥406 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated period.」
Discloses interim-period R&D expenses of ¥406 million and states that there have been no material changes in the status of R&D activities. - FY2025AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥802 million.」
R&D expenses increased from ¥621 million in the previous fiscal year to ¥802 million. In addition to product development, research into AI and XR is also progressing, including ARCHITREND ONE, FIELD-POCKET, TREND-CORE Ver.10 and TREND-POINT Ver.11.2. - FY2025-H1RestatedAnnual report
「Group-wide R&D expenses for the current interim consolidated period were ¥328 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated period.」
Reports interim-period R&D expenses of ¥328 million and reconfirms that there have been no material changes in R&D activities. - FY2024Lower R&D expenses; continued product developmentAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥621 million.」
R&D expenses decreased from ¥718 million in the previous fiscal year to ¥621 million, while development of new products and functions, including ARCHITREND, GLOOBE, TREND-ONE/Mercury-ONE, TREND-POINT, TREND ROAD Designer and CIMPHONY Plus, continued. - FY2024-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥457 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
Reports cumulative third-quarter R&D expenses of ¥457 million and reconfirms that there have been no material changes in the status of R&D activities. - FY2024-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥326 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
Recorded cumulative second-quarter R&D expenses of ¥326 million and reconfirmed that there have been no material changes in R&D activities. - FY2024-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥178 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
Reports cumulative first-quarter R&D expenses of ¥178 million and reconfirms that there have been no material changes in R&D activities. - FY2023AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥718 million.」
R&D expenses increased from ¥671 million in the previous fiscal year to ¥718 million. Specific product and service development also continued in the architectural systems, surveying and civil engineering systems, and IT solutions fields. - FY2023-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥539 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
Reports cumulative third-quarter R&D expenses of ¥539 million and reconfirms that there have been no material changes in R&D activities. - FY2023-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥343 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
Reports cumulative second-quarter R&D expenses of ¥343 million and reconfirms that there have been no material changes in R&D activities. - FY2023-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥190 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
Reconfirmed that there have been no material changes in R&D activities and reported cumulative first-quarter R&D expenses of ¥190 million. - FY2022AdvancedAnnual report
「The Group's R&D activities mainly comprise basic research into new technologies, development of new products, and improvements and enhancements to existing products. The total R&D expenses for the consolidated fiscal year were ¥671 million, including ¥5 million in basic research costs that cannot be allocated to individual segments.」
The Group continued its core R&D activities and carried out specific product updates, including ARCHITREND ZERO Ver.8, GLOOBE 2022, TREND-ONE Ver.5, TREND-CORE Ver.8 and TREND-POINT Ver.9. R&D expenses decreased from ¥836 million in the previous fiscal year to ¥671 million. - FY2022-Q3RestatedAnnual report
「The amount spent on research and development activities by the Group during the third quarter of the current consolidated cumulative period was ¥493 million. There were no material changes in the status of the Group's research and development activities during the third quarter of the current consolidated cumulative period.」
Reports cumulative third-quarter R&D expenses of ¥493 million and reconfirms that there have been no material changes in R&D activities. - FY2022-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥316 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
Reports cumulative second-quarter R&D expenses of ¥316 million and reconfirms that there have been no material changes in R&D activities. - FY2022-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥181 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
Recorded R&D expenses of ¥181 million and reconfirmed that there have been no material changes in the status of R&D activities. - FY2021AdvancedAnnual report
「The Group's R&D activities mainly comprise basic research into new technologies, development of new products, and improvements and enhancements to existing products. The total R&D expenses for the consolidated fiscal year were ¥836 million, including ¥0 million in basic research costs that cannot be allocated to individual segments.」
Basic research, new product development and improvements to existing products continued, and R&D expenses increased from ¥641 million in the previous fiscal year to ¥836 million. - FY2021-Q3RestatedAnnual report
「Group-wide R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥477 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
Reports cumulative third-quarter R&D expenses of ¥477 million and reconfirms that there have been no material changes in R&D activities. - FY2021-Q2RestatedAnnual report
「Group-wide R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥308 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
Reports first-half R&D expenses of ¥308 million and reconfirms that there have been no material changes in R&D activities. - FY2021-Q1RestatedAnnual report
「Group-wide R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥179 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
Reports cumulative first-quarter R&D expenses of ¥179 million and reconfirms that there have been no material changes in R&D activities. - FY2020AdvancedAnnual report
「The Group's R&D activities mainly comprise basic research into new technologies, development of new products, and improvements and enhancements to existing products. The total R&D expenses for the consolidated fiscal year were ¥641 million, including ¥7 million in basic research costs that cannot be allocated to individual segments.」
Basic research, new product development and improvements to existing products continued, and R&D expenses increased from ¥563 million in the previous fiscal year to ¥641 million. Specific development and releases, including ARCHITREND ZERO Ver.6, GLOOBE 2020, TREND-ONE Ver.4 and TREND-CORE Ver.6, were also reported. - FY2020-Q3RestatedAnnual report
「The Group’s R&D expenditure during the third quarter of the current consolidated cumulative period was ¥438 million. There were no significant changes in the status of the Group’s R&D activities during the third quarter of the current consolidated cumulative period.」
Reports cumulative R&D expenses of ¥438 million for the first 3 quarters and reconfirms that there have been no material changes in R&D activities. - FY2020-Q2RestatedAnnual report
「The Group’s total R&D expenses for the first half of the fiscal year were ¥263 million. There were no material changes in the status of the Group’s R&D activities during the first half.」
Reports R&D expenses of ¥263 million for the first half and reconfirms that there have been no material changes in R&D activities. - FY2020-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter of the fiscal year were ¥118 million. There were no material changes in the status of the Group’s R&D activities during the first quarter.」
The company reports cumulative R&D expenses of ¥118 million for the first quarter and reconfirms that there were no material changes in its R&D activities. - FY2019RestatedAnnual report
「The Group’s R&D activities primarily consist of basic research into new technologies, development of new products, and improvements and enhancements to existing products. Total R&D expenses for the consolidated fiscal year were ¥563 million.」
The company states that it continued its R&D activities centered on basic research, new product development and improvements to existing products, and reports R&D expenses of ¥563 million for the fiscal year. - FY2019-Q3RestatedAnnual report
「The Group’s total R&D expenses for the first nine months of the fiscal year were ¥372 million. There were no material changes in the status of the Group’s R&D activities during the first nine months.」
The company reports cumulative R&D expenses of ¥372 million for the first nine months and reconfirms that there were no material changes in its R&D activities. - FY2019-Q2RestatedAnnual report
「The Group’s total R&D expenses for the first half of the fiscal year were ¥217 million. There were no material changes in the status of the Group’s R&D activities during the first half.」
The company reconfirms that there were no material changes in its R&D activities and reports first-half R&D expenses of ¥217 million. - FY2019-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter of the fiscal year were ¥104 million. There were no material changes in the status of the Group’s R&D activities during the first quarter.」
The company reports R&D expenses of ¥104 million for the quarter and reconfirms that there were no material changes in its R&D activities. - FY2018RestatedAnnual report
「The Group’s R&D activities primarily consist of basic research into new technologies, development of new products, and improvements and enhancements to existing products. Total R&D expenses for the consolidated fiscal year were ¥696 million.」
The company reconfirms its policy of focusing its R&D activities on basic research, new product development, and improvements and enhancements to existing products, and reports annual R&D expenses of ¥696 million. - FY2018-Q3RestatedAnnual report
「The Group’s total R&D expenses for the first nine months of the fiscal year were ¥463 million. There were no material changes in the status of the Group’s R&D activities during the first nine months.」
The company reports cumulative R&D expenses of ¥463 million for the first nine months and reconfirms that there were no material changes in its R&D activities. - FY2018-Q2RestatedAnnual report
「The Group’s R&D expenditure during the second quarter of the current consolidated cumulative period was ¥275 million. There were no significant changes in the status of the Group’s R&D activities during the second quarter of the current consolidated cumulative period.」
The company reports cumulative R&D expenses of ¥275 million for the first half and reconfirms that there were no material changes in its R&D activities. - FY2018-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter of the fiscal year were ¥131 million. There were no material changes in the status of the Group’s R&D activities during the first quarter.」
The company reports R&D expenses of ¥131 million for the first quarter and reconfirms that there were no material changes in its R&D activities. - FY2017RestatedAnnual report
「The Group’s R&D activities primarily consist of basic research into new technologies, development of new products, and improvements and enhancements to existing products. Total R&D expenses for the consolidated fiscal year were ¥838 million.」
The company reconfirms its policy of focusing its R&D activities on basic research, new product development, and improvements and enhancements to existing products, and reports annual R&D expenses of ¥838 million. - FY2017-Q3RestatedAnnual report
「The Group’s total R&D expenses for the first nine months of the fiscal year were ¥606 million. There were no material changes in the status of the Group’s R&D activities during the first nine months.」
The company reports R&D expenses of ¥606 million for the first nine months and reconfirms that there were no material changes in its R&D activities. - FY2017-Q2RestatedAnnual report
「The amount spent on research and development activities by the Group during the second quarter of the current consolidated cumulative period was ¥417 million. There were no material changes in the status of the Group's research and development activities during the second quarter of the current consolidated cumulative period.」
The company reports cumulative quarterly R&D expenses of ¥417 million and reconfirms that there were no material changes in its R&D activities. - FY2017-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter of the fiscal year were ¥244 million. There were no material changes in the status of the Group’s R&D activities during the first quarter.」
The company reports quarterly R&D expenses of ¥244 million and reconfirms that there were no material changes in its R&D activities. - FY2016First statedAnnual report
「The Group’s R&D activities primarily consist of basic research into new technologies, development of new products, and improvements and enhancements to existing products. Total R&D expenses for the consolidated fiscal year were ¥908 million.」
The company identifies basic research, new product development and improvements to existing products as the pillars of its R&D activities, and reports R&D expenses of ¥908 million for the fiscal year.